Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 2, 2007, Pages 184-190

  Ahmed, Ashraf M ^a,b   Hussein, Amjad I A ^c   Shimamoto, Tadashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kafrelsheikh University   (Egypt)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Diabetic foot infections; Integrons; Multidrug resistance

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FLORFENICOL; GENTAMICIN; INTEGRIN; NALIDIXIC ACID; NEOMYCIN; NORFLOXACIN; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIABETIC FOOT; DNA DETERMINATION; DNA SEQUENCE; GENE CASSETTE; GENE STRUCTURE; GENETIC VARIABILITY; GENOMIC ISLAND; HUMAN; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; STRAIN IDENTIFICATION; BACTERIUM CONJUGATION; DRUG EFFECT; GENETICS; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MULTIGENE FAMILY;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CLONING, MOLECULAR; CONJUGATION, GENETIC; DIABETIC FOOT; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENOMIC ISLANDS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PROTEUS INFECTIONS; PROTEUS MIRABILIS; SALMONELLA;

EID: 33947526191     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl471     Document Type: Article

References (33)

1. O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000; 13: 534-46.
2. Liu PYF, Gur D, Hall LMC et al. Survey of the prevalence of β-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30 429-47.
3. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) report, data summary October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996; 24: 380-8.
4. Slovenkai MP. Foot problems in diabetes. Med Clin North Am 1998; 82: 949-71.
5. Boyd D, Peters GA, Cloeckaert A et al. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J Bacteriol 2001; 183: 5725-32.
6. Levings RS, Lightfoot D, Partridge SR et al. The genomic island SGI1, containing the multiple antibiotic resistance region of Salmonella enterica serovar Typhimurium DT104 or variants of it, is widely distributed in other S. enterica serovars. J Bacteriol 2005; 187: 4401-9.
7. Threlfall EJ. Epidemic Salmonella typhimurium DT104 - a truly international multiresistant clone. J Antimicrob Chemother 2000; 46: 7-10.
8. Threlfall EJ, Frost JA, Ward LR et al. Epidemic in cattle and humans of Salmonella typhimurium DT104 with chromosomally integrated drug resistance. Vet Rec 1994; 134: 577.
9. Meunier D, Boyd D, Mulvey MR et al. Salmonella enteric serotype Typhimurium DT104 antibiotic resistance genomic island I in serotype Paratyphi B. Emerg Infect Dis 2002; 8: 430-3.
10. Ebner P, Garner K, Mathew A. Class 1 integrons in various Salmonella enterica serovars isolated from animals and identification of genomic island SGI1 in Salmonella enterica var. Meleagridis. J Antimicrob Chemother 2004; 53: 1004-9.
11. Ahmed AM, Furuta K, Shimomura K et al. Characterization of a multidrug-resistant isolate of Salmonella Paratyphi B from Japan. J Antimicrob Chemother 2005; 56: 250.
12. Boyd D, Cloeckaert A, Chaslus-Dancla E et al. Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother 2002; 46: 1714-22.
13. Doublet B, Butaye P, Imberechts H et al. Salmonella Agona harboring genomic island 1-A. Emerg Infect Dis 2004; 10: 756-8.
14. Doublet B, Lailler R, Meunier D et al. Variant Salmonella genomic island 1 antibiotic resistance gene cluster in Salmonella enterica serovar Albany. Emerg Infect Dis 2003; 9: 585-91.
15. Doublet B, Weill FX, Fabre L et al. Variant Salmonella genomic island 1 antibiotic resistance gene cluster containing a novel 3′-N-aminoglycoside acetyltransferase gene cassette, aac(3 -ld, in Salmonella enterica serovar Newport. Antimicrob Agents Chemother 2004; 48: 3806-12.
16. Doublet B, Boyd D, Mulvey MR et al. The Salmonella genomic island 1 is an integrative mobilizable element. Mol Microbiol 2005; 55: 1911-24.
17. Burrus V, Pavlovic G, Decaris B et al. The ICESt1 element of Streptococcus thermophilus belongs to a large family of integrative and conjugative elements that exchange modules and change their specificity of integration. Plasmid 2002; 48: 77-97.
18. Ahmed AM, Nakano H, Shimamoto T. Molecular characterization of integrons in non-typhoid Salmonella serovars isolated in Japan: Description of an unusual class 2 integron. J Antimicrob Chemother 2005; 55 371-4.
19. National Committee for Clinical Laboratory Standards. Performance Standards for Disk Susceptibility Tests - Eighth Edition: Approved Standard M2-A8. NCCLS, Wayne, PA, USA, 2003.
20. Levesque C, Piche L, Larose C et al. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-91.
21. White PA, McIver CJ, Rawlinson WD. Integrons and gene cassettes in the Enterobacteriaceae. Antimicrob Agents Chemother 2001; 45: 2658-61.
22. +, Canada. Emerg Infect Dis 2004; 10: 1307-10.
23. Threlfall EJ, Ward LR, Rowe B. Increasing incidence of resistance to trimethoprim and ciprofloxacin in epidemic Salmonella typhimurium DT104 in England and Wales. Euro surveill 1997; 2: 81-4.
24. Fowler D, Rayman G. Foot infection. Diabet Med 2006; 23 Suppl 3: 18-21.
25. Lipsky BA, Berendt AR, Deery HG et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39: 885-910.
26. Ceccarelli D., Salvia AM, Sami J et al. New cluster of plasmid-located class 1 integrons in Vibrio cholerae O1 and a dfrA 15 cassette-containing integron in Vibrio parahaemolyticus isolated in Angola. Antimicrob Agents Chemother 2006; 50: 2493-9.
27. Adrian PV, Du Plessis M, Klugman KP et al. New trimethoprim-resistant dihydrofolate reductase cassette, dfrXV, inserted in a class 1 integron. Antimicrob Agents Chemother 1998; 42: 2221-4.
28. Cloeckaert A, Praud K, Doublet B et al. Variant Salmonella genomic island 1-L antibiotic resistance gene cluster in Salmonella enterica serovar Newport. Antimicrob Agents Chemother 2006; 50: 3944-6.
29. Ahmed AM, Nakagawa T, Arakawa E et al. New aminoglycoside acetyltransferase gene, aac(3)-ld, in a class 1 integron from a multiresistant strain of Vibrio fluvialis isolated from an infant aged 6 months. J Antimicrob Chemother 2004; 53: 947-51.
30. Boyd DA, Peters GA, Ng LK et al. Partial characterization of a genomic island associated with the multidrug resistance region of Salmonella enterica Typhimurium DT104. FEMS Microbiol Lett 2000; 189: 285-91.
31. Carlson ST, Wu MT. Avoidance of false PCR results with the integron-retron junction in multiple antibiotic resistant Salmonella enterica serotype Typhimurium. Mol Cell Probes 2003; 17: 183-6.
32. Sundström L, Roy PH, Sköld O. Site-specific insertion of three structural gene cassettes in transposon Tn7. J Bacteriol 1991; 173: 3025-8.
33. Tietze E, Brevet J, Tschäpe H. Relationships among the streptothricin resistance transposons Tn1825 and Tn1826 and the trimethoprim resistance transposon Tn7. Plasmid 1987; 18: 246-9.